Suppr超能文献

细胞因子介导的 ALK 家族受体激活的结构基础。

Structural basis of cytokine-mediated activation of ALK family receptors.

机构信息

Unit for Structural Biology, Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium.

Unit for Structural Biology, VIB-UGent Center for Inflammation Research, Ghent, Belgium.

出版信息

Nature. 2021 Dec;600(7887):143-147. doi: 10.1038/s41586-021-03959-5. Epub 2021 Oct 13.

Abstract

Anaplastic lymphoma kinase (ALK) and the related leukocyte tyrosine kinase (LTK) are recently deorphanized receptor tyrosine kinases. Together with their activating cytokines, ALKAL1 and ALKAL2 (also called FAM150A and FAM150B or AUGβ and AUGα, respectively), they are involved in neural development, cancer and autoimmune diseases. Furthermore, mammalian ALK recently emerged as a key regulator of energy expenditure and weight gain, consistent with a metabolic role for Drosophila ALK. Despite such functional pleiotropy and growing therapeutic relevance, structural insights into ALK and LTK and their complexes with cognate cytokines have remained scarce. Here we show that the cytokine-binding segments of human ALK and LTK comprise a novel architectural chimera of a permuted TNF-like module that braces a glycine-rich subdomain featuring a hexagonal lattice of long polyglycine type II helices. The cognate cytokines ALKAL1 and ALKAL2 are monomeric three-helix bundles, yet their binding to ALK and LTK elicits similar dimeric assemblies with two-fold symmetry, that tent a single cytokine molecule proximal to the cell membrane. We show that the membrane-proximal EGF-like domain dictates the apparent cytokine preference of ALK. Assisted by these diverse structure-function findings, we propose a structural and mechanistic blueprint for complexes of ALK family receptors, and thereby extend the repertoire of ligand-mediated dimerization mechanisms adopted by receptor tyrosine kinases.

摘要

间变性淋巴瘤激酶(ALK)和相关的白细胞酪氨酸激酶(LTK)是最近被发现的孤儿受体酪氨酸激酶。它们与其激活细胞因子,ALKAL1 和 ALKAL2(也称为 FAM150A 和 FAM150B 或 AUGβ 和 AUGα)一起,参与神经发育、癌症和自身免疫性疾病。此外,哺乳动物 ALK 最近被发现是能量消耗和体重增加的关键调节因子,这与果蝇 ALK 的代谢作用一致。尽管具有如此多的功能多样性和日益增长的治疗相关性,但对 ALK 和 LTK 及其与同源细胞因子复合物的结构见解仍然很少。在这里,我们展示了人类 ALK 和 LTK 的细胞因子结合片段由一个经过置换的 TNF 样模块的新型结构嵌合体组成,该模块支撑着一个富含甘氨酸的亚结构域,具有长的 II 型聚甘氨酸的六边形晶格。同源细胞因子 ALKAL1 和 ALKAL2 是单体三螺旋束,但它们与 ALK 和 LTK 的结合引发了具有二倍对称性的类似二聚体组装,将单个细胞因子分子帐篷靠近细胞膜。我们表明,膜近端的 EGF 样结构域决定了 ALK 的明显细胞因子偏好。在这些多样化的结构-功能发现的辅助下,我们提出了 ALK 家族受体复合物的结构和机制蓝图,并因此扩展了受体酪氨酸激酶采用的配体介导二聚化机制的范围。

相似文献

2
Mechanism for the activation of the anaplastic lymphoma kinase receptor.间变性淋巴瘤激酶受体激活的机制。
Nature. 2021 Dec;600(7887):153-157. doi: 10.1038/s41586-021-04140-8. Epub 2021 Nov 24.
6
7
Structural basis for ligand reception by anaplastic lymphoma kinase.异常性淋巴瘤激酶配体接受的结构基础。
Nature. 2021 Dec;600(7887):148-152. doi: 10.1038/s41586-021-04141-7. Epub 2021 Nov 24.
8
A hypothalamic pathway for Augmentor α-controlled body weight regulation.增敏素 α 控制体重调节的下丘脑通路。
Proc Natl Acad Sci U S A. 2022 Apr 19;119(16):e2200476119. doi: 10.1073/pnas.2200476119. Epub 2022 Apr 11.

引用本文的文献

6
ALK in cancer: from function to therapeutic targeting.癌症中的间变性淋巴瘤激酶:从功能到治疗靶点
Nat Rev Cancer. 2025 May;25(5):359-378. doi: 10.1038/s41568-025-00797-9. Epub 2025 Mar 7.

本文引用的文献

1
Searching protein space for ancient sub-domain segments.在蛋白质空间中搜索古老的亚域片段。
Curr Opin Struct Biol. 2021 Jun;68:105-112. doi: 10.1016/j.sbi.2020.11.006. Epub 2021 Jan 18.
5
Identification of ALK in Thinness.瘦素中的 ALK 的鉴定。
Cell. 2020 Jun 11;181(6):1246-1262.e22. doi: 10.1016/j.cell.2020.04.034. Epub 2020 May 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验